• Home

  • About

  • Team

  • Platform

  • News

  • Careers

  • Contact

  • More

    Developing
    Best-in-Class
    Vaccines
    Computationally Designed VLP Vaccines

    By utilizing computationally designed proteins that self-assemble into virus-like particles (VLPs), we are able to readily manufacture VLPs displaying complex antigens to target significant unmet medical needs.

    RSV Vaccine
    Our first vaccine candidate, IVX-121, is being developed to protect older adults from respiratory syncytial virus (RSV) disease.
    Icosavax is unlocking a whole class of challenging vaccine targets to improve human health.
    LEARN MORE »
    In the News
    Icosavax Logo White 2-03.png

    Icosavax, Inc.

    2815 Eastlake Ave E, Suite 300

    Seattle, WA 98102

    info@icosavax.com

    • White Twitter Icon
    • White Facebook Icon
    • White LinkedIn Icon
    SEND US A MESSAGE

    Thanks for submitting!

    © 2019 Icosavax, Inc. All rights reserved. 

    Privacy Policy  |  Terms of Use